The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective

被引：921

作者：

Mahmood, Syed S. ^{[1
]}

Levy, Daniel ^{[2
,3
]}

Vasan, Ramachandran S. ^{[2
,4
,5
]}

Wang, Thomas J. ^{[2
,6
]}

机构：

[1] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA

[2] NHLBI, Framingham Heart Study, Framingham, MA USA

[3] NHLBI, Populat Res Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA

[4] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA

[5] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA

[6] Vanderbilt Univ, Div Cardiovasc Med, Nashville, TN 37235 USA

来源：

LANCET | 2014年 / 383卷 / 9921期

关键词：

RISK-FACTORS; FOLLOW-UP; SYSTOLIC HYPERTENSION; ATRIAL-FIBRILLATION; DIABETES-MELLITUS; NATURAL-HISTORY; BLOOD-PRESSURE; FAILURE; POPULATION; MORTALITY;

D O I：

10.1016/S0140-6736(13)61752-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

On Sept 29, 2013, the Framingham Heart Study will celebrate 65 years since the examination of the first volunteer in 1948. During this period, the study has provided substantial insight into the epidemiology and risk factors of cardiovascular disease. The origins of the study are closely linked to the cardiovascular health of President Franklin D Roosevelt and his premature death from hypertensive heart disease and stroke in 1945. In this Review we describe the events leading to the foundation of the Framingham Heart Study, and provide a brief historical overview of selected contributions from the study.

引用

页码：999 / 1008

页数：10

共 50 条

[1] The Contribution of the Framingham Heart Study to the Prevention of Cardiovascular Disease: A Global Perspective
Mendis, Shanthi
PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 53 (01) : 10 - 14
[2] Contributions of the Framingham Heart Study to the Epidemiology of Coronary Heart Disease
Chen, George
Levy, Daniel
JAMA CARDIOLOGY, 2016, 1 (07) : 825 - 830
[3] The burden of cardiovascular disease: The Framingham heart study
Peeters, A
Mamun, A
Willekens, F
Bonneux, L
EUROPEAN HEART JOURNAL, 2001, 22 : 630 - 630
[4] Hypertension and Cardiovascular Disease: Contributions of the Framingham Heart Study
Franklin, Stanley S.
Wong, Nathan D.
GLOBAL HEART, 2013, 8 (01) : 49 - 57
[5] EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
CASTELLI, WP
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A): : 4 - 12
[6] Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology
Tsao, Connie W.
Vasan, Ramachandran S.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (06) : 1800 - 1813
[7] Serum potassium and risk of cardiovascular disease - The Framingham Heart Study
Walsh, CR
Larson, MG
Leip, ER
Vasan, RS
Levy, D
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) : 1007 - 1012
[8] Impaired fasting glucose and cardiovascular disease: The Framingham heart study
Levitzky, Yamini S.
Pencina, Michael J.
D'Agostino, Ralph B.
Meigs, James B.
Murabito, Joanne M.
Vasan, Ramachandran S.
Fox, Caroline S.
DIABETES, 2006, 55 : A1 - A1
[9] Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study
Lahoz, C
Schaefer, EJ
Cupples, LA
Wilson, PWF
Levy, D
Osgood, D
Parpos, S
Pedro-Botet, J
Daly, JA
Ordovas, JM
ATHEROSCLEROSIS, 2001, 154 (03) : 529 - 537
[10] Diabetes and Cardiovascular Disease: Insights from the Framingham Heart Study
Qazi, Mohammad U.
Malik, Shaista
GLOBAL HEART, 2013, 8 (01) : 43 - 48

← 1 2 3 4 5 →